Show simple item record

dc.contributor.authorNemmara, Venkatesh V.
dc.contributor.authorThompson, Paul R
dc.date2022-08-11T08:10:31.000
dc.date.accessioned2022-08-23T17:11:58Z
dc.date.available2022-08-23T17:11:58Z
dc.date.issued2018-09-11
dc.date.submitted2018-12-20
dc.identifier.citation<p>Curr Top Microbiol Immunol. 2018 Sep 11. doi: 10.1007/82_2018_132. [Epub ahead of print]</p>
dc.identifier.issn0070-217X
dc.identifier.doi10.1007/82_2018_132
dc.identifier.pmid30203394
dc.identifier.urihttp://hdl.handle.net/20.500.14038/46402
dc.description.abstractProtein arginine deiminases (PADs) catalyze the post-translational deimination of peptidyl arginine to form peptidyl citrulline. This modification is increased in multiple inflammatory diseases and in certain cancers. PADs regulate a variety of signaling pathways including apoptosis, terminal differentiation, and transcriptional regulation. Activity-based protein profiling (ABPP) probes have been developed to understand the role of the PADs in vivo and to investigate the effect of protein citrullination in various pathological conditions. Furthermore, these ABPPs have been utilized as a platform for high-throughput inhibitor discovery. This review will showcase the development of ABPPs targeting the PADs. In addition, it provides a brief overview of PAD structure and function along with recent advances in PAD inhibitor development.
dc.language.isoen_US
dc.publisherSpringer Verlag
dc.relation<p><a href="https://www.ncbi.nlm.nih.gov/pubmed/30203394" target="_blank">Link to article in PubMed</a></p>
dc.relation.urlhttps://doi.org/10.1007/82_2018_132
dc.subjectBiochemistry
dc.subjectEnzymes and Coenzymes
dc.subjectMedicinal-Pharmaceutical Chemistry
dc.titleDevelopment of Activity-Based Proteomic Probes for Protein Citrullination.
dc.typeJournal Article
dc.source.journaltitleCurrent topics in microbiology and immunology
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/publications/12
dc.identifier.contextkey13517630
html.description.abstract<p>Protein arginine deiminases (PADs) catalyze the post-translational deimination of peptidyl arginine to form peptidyl citrulline. This modification is increased in multiple inflammatory diseases and in certain cancers. PADs regulate a variety of signaling pathways including apoptosis, terminal differentiation, and transcriptional regulation. Activity-based protein profiling (ABPP) probes have been developed to understand the role of the PADs in vivo and to investigate the effect of protein citrullination in various pathological conditions. Furthermore, these ABPPs have been utilized as a platform for high-throughput inhibitor discovery. This review will showcase the development of ABPPs targeting the PADs. In addition, it provides a brief overview of PAD structure and function along with recent advances in PAD inhibitor development.</p>
dc.identifier.submissionpathpublications/12
dc.contributor.departmentProgram in Chemical Biology
dc.contributor.departmentDepartment of Biochemistry and Molecular Pharmacology
dc.contributor.departmentThompson Lab


This item appears in the following Collection(s)

Show simple item record